3:10–3:30 pm Friday, September 4

Paper Presentation: Symptom Reporting Strategies—Patient and Parent Experiences of Cancer Symptoms as Assessed by the Memorial Symptom Assessment Scale for Children (231-3)

Treatment for childhood cancer is associated with symptoms that contribute to poorer psychological and physical functioning and decreased quality of life. Symptom assessment scales have been used to identify the prevalence, severity, and distress related to cancer treatment.

Read more...
Speaker:
Melody Hellsten, DNP APRN PPCNP-BC CHPPN
CNE Hours
0.34
2:50 – 3:10 pm Friday, September 4

Paper Presentation: Symptom Reporting Strategies—Perceived Usefulness and User Satisfaction of Electronic and Paper-and-Pencil Symptom Tracking Diaries for Young Children with Cancer: Parent Perspectives (231-2)

"Because much of the cancer care for young children occurs in the outpatient setting, parents have the responsibility of identifying and responding to the child’s symptoms at home. Having a tool that parents could use to record their child's daily symptoms could help to provide insight into the symptoms the child is experiencing. Although multiple resources have been developed to support symptom tracking, ensuring usability is key.

Read more...
Speaker:
Sharifa Al-Qaaydeh, PhD RN
CNE Hours
0.33
2:30 – 2:50 pm Friday, September 4

Paper Presentation: Symptom Reporting Strategies—Examining Self-Reported Pain of School-Age Children Undergoing Treatment for Cancer Using a Game-Based App (231-1)

The goal of this presentation is to describe the daily pain experiences reported by 19 school-age children with cancer participating in a trial of a game-based symptom assessment app. We will discuss the prevalence of pain and how participants elected to communicate their pain within the app, using child-centric rating scales, an avatar to localize pain, and free-text responses.

Read more...
Speaker:
Katherine Bernier Carney, PhD RN
CNE Hours
0.33
2:30 – 3:30 pm Friday, September 4

Below the Surface:  Applying Evidence-Based Practice in Skin Care Management with the Hematopoietic Cell Transplant Patient (229)

Children and adolescents undergoing hematopoietic cell transplant (HCT) are at high risk for developing skin complications. Nurses play a vital role in the assessment, prevention, and management of skin issues in this population where multiple factors lead to skin complications.

Read more...
Speaker:

Nancy Noonan, MS RN PCNS-BC BMTCN®

Linda Abramovitz, MSN RN CNS FAAN BMTCN®

Lisa Pinner, RN MSN CNS BMTCN® CPON® 

CNE Hours
1
12:15 – 1:15 pm Friday, September 4

High Risk Neuroblastoma in the new decade: Incorporating targeted therapies to maximize impact in current Children’s Oncology Group trials (C226)

coglogoWhile the overall cure rate for childhood cancer is approaching 80%, the prognosis for long-term survival for children with high risk neuroblastoma lags considerably behind, at 50%–60%. Upfront standard treatment for high-risk neuroblastoma protocols within the Children’s Oncology Group (COG) has historically utilized all available modalities of cancer treatment including chemotherapy, surgery, myeloablative chemotherapy with stem cell rescue, radiation therapy, differentiating agents, and most recently biologic therapy with anti-GD2 antibody (dinutuximab) used post consolidation in ANBL0032.

Read more...
Speaker:

Wendy Fitzgerald, MSN APRN PPCNP-BC

Denise Mills, MN RN(EC) NP CPHON®

CNE Hours
1
12:15 – 1:15 pm Friday, September 4

Adopt, Adapt, Advance: Utilizing Evidence Based Practice, Quality Improvement and Nursing Research to Transform Pediatric Hematology/Oncology Nursing Practice (224)

Nursing research (NR), evidence-based practice (EBP), and quality improvement (QI) are principal methods of clinical inquiry and provide unique contributions to the science of pediatric hematology oncology nursing. Each of these methodologies have distinct similarities and differences. Due to their complexity, differentiating between the three can be challenging.

Read more...
Speaker:

Micah Skeens, PhD RN CPNP

Mindy Bibart, MSN RN NE-BC CSSBB CPHON®

Misty Evans, DNP APRN CPNP-AC BMTCN®

CNE Hours
1
2:30 – 3:30 pm Thursday, September 3

Marijuana, Hemp, and the Child with Cancer (217)

Many pediatric oncology patients report medical marijuana (MMJ) and hemp-based CBD use. Over 4,000 children are registered users of marijuana in Colorado, the first state to legalize recreational marijuana. Eleven states and Washington, DC have legalized marijuana for recreational use for adults older than 21.

Read more...
Speaker:
Molly Hemenway, DNP MS AC/PC-CPNP
CNE Hours
1
12:15 – 1:15 pm Thursday, September 3

Caring for Pediatric Patients with Malignant Bone Tumors: The Advanced Practice Nurse’s Perspective (213)

Children, adolescents, and young adults with malignant bone tumors require expert and specialized care beginning at diagnosis and continuing throughout therapy and beyond. Each patient’s treatment plan is likely to include systemic chemotherapy plus radiation and/or surgery to achieve local tumor control.

Read more...
Speaker:
Kristen Dalton, MSN RN CPNP-AC CPHON®
Elizabeth Cummings, MSN RN CPNP-AC CPHON®
Amy Rapino, MSN CRNP
CNE Hours
1
4:10 – 4:30 pm Wednesday, September 2

Paper Presentation: Symptoms Across the Cancer Continuum— Comparison of Symptom Reports Among Children with Advanced Cancer and Their Parents (209-3)

Using patient-reported outcomes to elicit a child’s symptom experience is the gold standard; however, little empirical evidence exists demonstrating consistent integration of self-report of physical and psychological symptoms across clinical settings. Additionally, studies have revealed discordance among children and parents for symptom reporting during cancer treatment.

Read more...
Speaker:
Kathleen Montgomery, PhD RN PCNS-BC CPHON®
Jessica Ward, PhD MPH CPNP RN
CNE Hours
0.34
3:50 – 4:10 pm Wednesday, September 2

Paper Presentation: Symptoms Across the Cancer Continuum—Symptoms and Quality of Life of Children and Adolescents Receiving Cellular Therapies (209-2)

Hematopoietic stem cell transplantation (HSCT) and chimeric antigen receptor (CAR) T-cell therapy are potentially curative therapies for children with life-threatening conditions but can result in a high symptom burden and poor quality of life (QoL).

Read more...
Speaker:
Jessica Ward, PhD MPH CPNP RN
CNE Hours
0.33
Subscribe to this RSS feed